临床心身疾病杂志
臨床心身疾病雜誌
림상심신질병잡지
JOURNAL OF CLINICAL PSYCHOSOMATIC DISEASES
2014年
3期
107-108
,共2页
精神分裂症%氯氮平%抗精神病药物%合理用药%单一用药%联合用药
精神分裂癥%氯氮平%抗精神病藥物%閤理用藥%單一用藥%聯閤用藥
정신분렬증%록담평%항정신병약물%합리용약%단일용약%연합용약
Schizophrenia%clozapine%antipsychotic%rational administration%single medication%drug com-bination
目的:了解氯氮平在住院男性精神分裂症中的应用状况。方法对120例住院男性精神分裂症患者应用氯氮平治疗状况进行调查分析。结果本组男性精神分裂症患者氯氮平使用率为65.0%,其中97.4%的病程≥5a,64.1%的经济状况较差(农村低保);单一用药占38.5%,两药联用占55.1%,三药联用占6.4%;氯氮平联合第一代及第二代抗精神病药物的概率均为17.9%,联合情绪稳定剂的概率为20.5%。结论住院男性精神分裂症患者应用氯氮平的频率较高。氯氮平多用于病程≥5a,且经济状况较差的精神分裂症患者,以联合用药为主,临床医生应严格掌握用药适应证,注重患者的远期疗效及认知功能、社会功能的恢复。
目的:瞭解氯氮平在住院男性精神分裂癥中的應用狀況。方法對120例住院男性精神分裂癥患者應用氯氮平治療狀況進行調查分析。結果本組男性精神分裂癥患者氯氮平使用率為65.0%,其中97.4%的病程≥5a,64.1%的經濟狀況較差(農村低保);單一用藥佔38.5%,兩藥聯用佔55.1%,三藥聯用佔6.4%;氯氮平聯閤第一代及第二代抗精神病藥物的概率均為17.9%,聯閤情緒穩定劑的概率為20.5%。結論住院男性精神分裂癥患者應用氯氮平的頻率較高。氯氮平多用于病程≥5a,且經濟狀況較差的精神分裂癥患者,以聯閤用藥為主,臨床醫生應嚴格掌握用藥適應證,註重患者的遠期療效及認知功能、社會功能的恢複。
목적:료해록담평재주원남성정신분렬증중적응용상황。방법대120례주원남성정신분렬증환자응용록담평치료상황진행조사분석。결과본조남성정신분렬증환자록담평사용솔위65.0%,기중97.4%적병정≥5a,64.1%적경제상황교차(농촌저보);단일용약점38.5%,량약련용점55.1%,삼약련용점6.4%;록담평연합제일대급제이대항정신병약물적개솔균위17.9%,연합정서은정제적개솔위20.5%。결론주원남성정신분렬증환자응용록담평적빈솔교고。록담평다용우병정≥5a,차경제상황교차적정신분렬증환자,이연합용약위주,림상의생응엄격장악용약괄응증,주중환자적원기료효급인지공능、사회공능적회복。
Objective To survey clozapine application status of hospitalized male schizophrenics .Methods Time-point surveys of drug application status were conducted in 120 hospitalized male schizophrenics who were treated with clozapine .Results Clozapine use rate was 65 .0% in hospital-ized male schizophrenics ,97 .4% of them had course ≥ 5 years ,64 .1% did poor economic status (rural low-security);single medication made up 38 .5% ,two drugs combination 55/1% and three 6 .4% ;proba-bility of clozapine plus first and second generation antipsychotic was 17 .9% ,that of plus stabilizer 20 .5% . Conclusion Clozapine use frequency is higher in hospitalized male schizophrenics .Clozapine is mainly used in patients whose courses are ≥ 5 years and who have poor economic status ,drug combination is main treatment method ,clinicians should master indication strictly ,pay attention to long-term efficacy , cognitive function and social function recovery .